Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron chelation therapies

PARTIALLY ADDRESSED

Iron-dependent cell death (ferroptosis) as a mechanism in ALS and motor neuron diseases. Focus on GPX4 (glutathione peroxidase 4), lipid peroxidation, system Xc- cystine/glutamate antiporter, and iron chelation therapies.

Priority: 0.85 Domain: neurodegeneration Hypotheses: 0

📊 Landscape Analysis

Landscape Summary: Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron chelation therapies is a 0.85 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

Ferroptosis in ALS and motor neuron disease: GPX4, lipid peroxidation, and iron chelation therapies — INVOKE-2 (completed)

📈 Living Dashboards

Hypotheses

0.000

Top Score

0.000

Avg Score

Debates

0.59

Avg Quality

60%

Resolution

Mechanistic Families

Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (20)

TNF→FerroptosisInflammation→FerroptosisP53→FerroptosisCancer→FerroptosisGPX4→Als

▸ Show 15 more

SLC7A11→FerroptosisAKT→FerroptosisTumor→FerroptosisPI3K→FerroptosisAls→FerroptosisAMPK→FerroptosisGPX4→TumorGPX4→STINGBECN1→FerroptosisGENES→FerroptosisGPX4→NRF2GPX4→FerroptosisCarcinoma→FerroptosisSLC7A11→GPX4Neurodegeneration→Ferroptosis

associated with (11)

entities-hepcidin→ALSentities-microtubules→ALSentities-atp7b-gene→ALSentities-astrocytes→ALSentities-glp1-receptor→ALS

▸ Show 6 more

entities-histone-methylation→ALSentities-reactive-oxygen-species→ALSentities-heat-shock-proteins→ALSentities-ros→ALSMIRO1→ALSAls→Ferroptosis

▸ Show 2 more

GENES→FerroptosisGPX4→NRF2

regulates (5)

Tumor→FerroptosisCancer→FerroptosisSLC7A11→GPX4Als→FerroptosisGPX4→Cancer

therapeutic target (4)

GPX4→TumorInflammation→FerroptosisAls→FerroptosisCancer→Ferroptosis

🕑 Activity Feed

✏ update on knowledge_gap by None 2026-04-25T22:15

🎭 Ferroptosis in ALS and motor neuron disease: GPX4, lipid per q=0.59 2026-04-16T22:59

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions
Enrich with Semantic Scholar citations
Map to clinical trial endpoints

← Back to All Gaps